FDA Adverse Event Injury Summary report: N

ILET BIONIC PANCREAS

MDR report key: 23938762 · Received December 31, 2025

Report

Report Number
3019004087-2025-18380
Event Type
Injury
Date Received
December 31, 2025
Date of Event
December 23, 2025
Report Date
December 31, 2025
Manufacturer
BETA BIONICS INC.
Product Code
QFG
UDI-DI
850050080015
PMA / PMN Number
K231485
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 0

IT WAS REPORTED THAT THE USER EXPERIENCED HYPERGLYCEMIA WHILE USING THE ILET WITH A CD STEEL 6 MM, 23-INCH INFUSION SET, LOT 6013997, AFTER A RECENT SUPPLY CHANGE; THE USER SUSPECTED THE INFUSION SITE WAS IN SCAR TISSUE, OBSERVED INSULIN LEAKING FROM THE PRIOR SITE UPON REMOVAL, AND PERFORMED A GUIDED SITE CHANGE INCLUDING FILL TUBING AND FILL CANNULA, AFTER WHICH INSULIN THERAPY RESUMED. SYMPTOMS INCLUDED ELEVATED BLOOD GLUCOSE OF 383 MG/DL WITHOUT REPORTED PHYSICAL SYMPTOMS. OUTCOMES INCLUDED CONTINUATION OF INSULIN THERAPY WITH PLANNED FOLLOW-UP ON BLOOD GLUCOSE. INVESTIGATION INCLUDED CUSTOMER SUPPORT TROUBLESHOOTING AND EDUCATION ON SITE CHANGE AND PRIMING STEPS. INVESTIGATION OF THIS CASE REVEALED A PROBABLE INFUSION SITE ABSORPTION ISSUE WITH SUSPECTED USE OF SCAR TISSUE AND LEAKAGE UPON SITE REMOVAL, CONSISTENT WITH DELIVERY WITHOUT ABSORPTION AT THE PRIOR SITE. IT WAS CONCLUDED, BASED ON PREVIOUSLY ESTABLISHED FINDINGS FOR SIMILAR REPORTS, THAT THE CAUSE WAS UNDETERMINED. IF THE DEVICE IS RETURNED, A PHYSICAL EVALUATION WILL BE PERFORMED, AND A SUPPLEMENTAL WILL BE SUBMITTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2847888 ILET BIONIC PANCREAS ALTERNATE CONTROLLER ENABLED INSULIN INFUSION PUMP QFG BETA BIONICS INC. BB1001 850050080015

Patients

Seq Age Sex Outcome Treatment
1 68 YR Female Other